Search the Community
Showing results for tags 'dysmotility'.
Anti-RNPC3 (U11/U12) antibodies in systemic sclerosis are associated with moderate to severe gastrointestinal dysmotility. After adjusting for relevant covariates and potential confounders, moderate to severe GI disease was associated with anti-RNPC3 antibodies. PubMed, Arthritis Care Res (Hoboken), 09/22/2018. (Also see Antibodies and Dysmotility) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.